Numida meleagris isolate 19003 breed g44 Domestic line chromosome 8, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007821.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger C4H2-type containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger C4H2-type containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger C4H2-type containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger C4H2 domain-containing protein isoform X3
zinc finger C4H2 domain-containing protein isoform X2
zinc finger C4H2 domain-containing protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
LAS1 like, ribosome biogenesis factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
LAS1 like, ribosome biogenesis factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ribosomal biogenesis protein LAS1L isoform X1
ribosomal biogenesis protein LAS1L isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
rho GTPase-activating protein 20-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
rho GTPase-activating protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
rho GTPase-activating protein 20-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 20-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
rho GTPase-activating protein 20-like isoform X1
rho GTPase-activating protein 20-like isoform X2
V-set and immunoglobulin domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
V-set and immunoglobulin domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
V-set and immunoglobulin domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
V-set and immunoglobulin domain-containing protein 4 isoform X2
V-set and immunoglobulin domain-containing protein 4 isoform X1
heat shock factor protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
heat shock factor protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable G-protein coupled receptor 83, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable G-protein coupled receptor 83, transcript variant X3
probable G-protein coupled receptor 83, transcript variant X2
ectodysplasin A2 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ectodysplasin A2 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
StAR related lipid transfer domain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
stAR-related lipid transfer protein 8 isoform X4
StAR related lipid transfer domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
StAR related lipid transfer domain containing 8, transcript variant X9
StAR related lipid transfer domain containing 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
StAR related lipid transfer domain containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
StAR related lipid transfer domain containing 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
stAR-related lipid transfer protein 8 isoform X5
StAR related lipid transfer domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
StAR related lipid transfer domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
stAR-related lipid transfer protein 8 isoform X1
stAR-related lipid transfer protein 8 isoform X2
StAR related lipid transfer domain containing 8, transcript variant X8
stAR-related lipid transfer protein 8 isoform X3
relaxin receptor 1-like, transcript variant X3
relaxin receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
relaxin receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
relaxin receptor 1-like, transcript variant X6
relaxin receptor 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
relaxin receptor 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC110403278, transcript variant X1
uncharacterized LOC110403278, transcript variant X2
uncharacterized LOC110403319, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110403319, transcript variant X2
uncharacterized LOC110403319, transcript variant X1
uncharacterized LOC110403457, transcript variant X2
uncharacterized LOC110403457, transcript variant X1
uncharacterized LOC110403279, transcript variant X2
uncharacterized LOC110403279, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 155 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
leucine-rich repeat-containing protein 32-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
immunoglobulin binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
immunoglobulin-binding protein 1 isoform X1
immunoglobulin-binding protein 1 isoform X2
diacylglycerol O-acyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
diacylglycerol O-acyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
diacylglycerol O-acyltransferase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
diacylglycerol O-acyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
diacylglycerol O-acyltransferase 2-like isoform X2
diacylglycerol O-acyltransferase 2-like isoform X3
diacylglycerol O-acyltransferase 2-like isoform X1
diacylglycerol O-acyltransferase 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
diacylglycerol O-acyltransferase 2-like, transcript variant X6
diacylglycerol O-acyltransferase 2-like isoform X4
diacylglycerol O-acyltransferase 2-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like isoform X2
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
RAB41, member RAS oncogene family, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X8
RAB41, member RAS oncogene family, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X1
RAB41, member RAS oncogene family, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RAB41, member RAS oncogene family, transcript variant X9
PCTP-like protein, transcript variant X3
PCTP-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
PCTP-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
PCTP-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
PCTP-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
kinesin family member 4A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
kinesin family member 4A, transcript variant X2
chromosome-associated kinesin KIF4A isoform X1
chromosome-associated kinesin KIF4A isoform X2
TATA-box binding protein associated factor 9b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transcription initiation factor TFIID subunit 9B
fibronectin type-III domain-containing protein 3a-like, transcript variant X1
fibronectin type-III domain-containing protein 3a-like, transcript variant X2
fibronectin type-III domain-containing protein 3a-like
cysteinyl leukotriene receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cysteinyl leukotriene receptor 1, transcript variant X2
cysteinyl leukotriene receptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
lysophosphatidic acid receptor 4-like isoform X2
lysophosphatidic acid receptor 4-like isoform X3
lysophosphatidic acid receptor 4-like isoform X1
lysophosphatidic acid receptor 4-like isoform X4
uncharacterized LOC110403162, transcript variant X4
uncharacterized LOC110403162, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110403162, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110403162, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110403162, transcript variant X2
lysophosphatidic acid receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
lysophosphatidic acid receptor 4, transcript variant X2
putative P2Y purinoceptor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
putative P2Y purinoceptor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T-box transcription factor TBX22 isoform X1
T-box transcription factor TBX22 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X5
ecto-NOX disulfide-thiol exchanger 2, transcript variant X1
ecto-NOX disulfide-thiol exchanger 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2 isoform X3
ecto-NOX disulfide-thiol exchanger 2 isoform X2
ecto-NOX disulfide-thiol exchanger 2 isoform X5
ecto-NOX disulfide-thiol exchanger 2 isoform X1
ecto-NOX disulfide-thiol exchanger 2 isoform X4
ecto-NOX disulfide-thiol exchanger 2 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
glucose-dependent insulinotropic receptor
solute carrier family 25 member 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
brain mitochondrial carrier protein 1 isoform X1
solute carrier family 25 member 14, transcript variant X3
solute carrier family 25 member 14, transcript variant X2
brain mitochondrial carrier protein 1 isoform X2
ras-related protein Rab-33A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RNA-binding motif protein, X-linked 2 isoform X1
ras-related protein Rab-33A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ras-related protein Rab-33A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
methionyl-tRNA synthetase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
apoptosis inducing factor mitochondria associated 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
apoptosis-inducing factor 1, mitochondrial
BCL6 corepressor like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BCL6 corepressor like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
BCL-6 corepressor-like protein 1 isoform X2
BCL-6 corepressor-like protein 1 isoform X1
UTP14A, small subunit processome component, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
UTP14A, small subunit processome component, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
U3 small nucleolar RNA-associated protein 14 homolog A isoform X2
U3 small nucleolar RNA-associated protein 14 homolog A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
SAM and SH3 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SAM and SH3 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SAM and SH3 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
SAM and SH3 domain-containing protein 3 isoform X2
SAM and SH3 domain-containing protein 3 isoform X3
SAM and SH3 domain-containing protein 3 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: xaa-Pro aminopeptidase 2
OCRL, inositol polyphosphate-5-phosphatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
OCRL, inositol polyphosphate-5-phosphatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
OCRL, inositol polyphosphate-5-phosphatase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
OCRL, inositol polyphosphate-5-phosphatase, transcript variant X2
OCRL, inositol polyphosphate-5-phosphatase, transcript variant X4
inositol polyphosphate 5-phosphatase OCRL-1 isoform X5
inositol polyphosphate 5-phosphatase OCRL-1 isoform X2
inositol polyphosphate 5-phosphatase OCRL-1 isoform X4
inositol polyphosphate 5-phosphatase OCRL-1 isoform X3
inositol polyphosphate 5-phosphatase OCRL-1 isoform X1
ERCC excision repair 6 like, spindle assembly checkpoint helicase
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC110403384, transcript variant X2
uncharacterized LOC110403384, transcript variant X1
probable E3 ubiquitin-protein ligase MID2
TSC22 domain family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
TSC22 domain family protein 3 isoform X1
TSC22 domain family member 3, transcript variant X2
TSC22 domain family protein 3 isoform X2
uncharacterized LOC110403227, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110403227, transcript variant X2
uncharacterized protein LOC110403227 isoform X1
uncharacterized protein LOC110403227 isoform X2
chloride intracellular channel protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G2/mitotic-specific cyclin-B3 isoform X1
G2/mitotic-specific cyclin-B3 isoform X2
diacylglycerol kinase kappa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
diacylglycerol kinase kappa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
diacylglycerol kinase kappa, transcript variant X3
shroom family member 4, transcript variant X3
shroom family member 4, transcript variant X1
shroom family member 4, transcript variant X4
shroom family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphorylase kinase regulatory subunit alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
phosphorylase kinase regulatory subunit alpha 1, transcript variant X1
phosphorylase kinase regulatory subunit alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
phosphorylase kinase regulatory subunit alpha 1, transcript variant X3
phosphorylase kinase regulatory subunit alpha 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X1
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X2
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X3
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X4
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X5
phosphorylase kinase regulatory subunit alpha 1, transcript variant X6
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
PIH1 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
PIH1 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PIH1 domain containing 3, transcript variant X2
PIH1 domain containing 3, transcript variant X4
FERM and PDZ domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
FERM and PDZ domain-containing protein 3 isoform X2
FERM and PDZ domain containing 3, transcript variant X1
FERM and PDZ domain-containing protein 3 isoform X1
phosphoribosyl pyrophosphate synthetase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
thymosin beta 15B, transcript variant X2
thymosin beta 15B, transcript variant X1
thymosin beta 15B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
RAB9B, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RAB9B, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAB9B, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
proteolipid protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proteolipid protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glycine receptor alpha 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycine receptor alpha 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glycine receptor alpha 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycine receptor subunit alpha-4 isoform X2
glycine receptor subunit alpha-4 isoform X3
glycine receptor subunit alpha-4 isoform X1
galactosidase alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
galactosidase alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Bruton tyrosine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Bruton tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Bruton tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Bruton tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
translocase of inner mitochondrial membrane 8A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim8 A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
TATA-box binding protein associated factor 7 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
transcription initiation factor TFIID subunit 7-like isoform X1
TATA-box binding protein associated factor 7 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription initiation factor TFIID subunit 7-like isoform X2
aryl-hydrocarbon-interacting protein-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
dystrophin related protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dystrophin related protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC110403028, transcript variant X2
uncharacterized LOC110403028, transcript variant X1
centromere protein I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
centromere protein I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tRNA (uracil(54)-C(5))-methyltransferase homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GBYG01027645.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 491 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 491 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
H/ACA ribonucleoprotein complex subunit 4
coagulation factor VIII, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
coagulation factor VIII, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
mature T-cell proliferation 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
mature T-cell proliferation 1, transcript variant X1
BRCA1/BRCA2-containing complex subunit 3
germ cell nuclear acidic peptidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
germ cell nuclear acidic peptidase, transcript variant X2
acidic repeat-containing protein isoform X1
acidic repeat-containing protein isoform X2
O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
TATA-box binding protein associated factor 1, transcript variant X4
TATA-box binding protein associated factor 1, transcript variant X5
TATA-box binding protein associated factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
TATA-box binding protein associated factor 1, transcript variant X3
TATA-box binding protein associated factor 1, transcript variant X1
TATA-box binding protein associated factor 1, transcript variant X6
transcription initiation factor TFIID subunit 1 isoform X4
transcription initiation factor TFIID subunit 1 isoform X5
transcription initiation factor TFIID subunit 1 isoform X2
transcription initiation factor TFIID subunit 1 isoform X3
transcription initiation factor TFIID subunit 1 isoform X1
transcription initiation factor TFIID subunit 1 isoform X6
rho-related GTP-binding protein RhoG-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
rho-related GTP-binding protein RhoG-like, transcript variant X1
rho-related GTP-binding protein RhoG-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho-related GTP-binding protein RhoG-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
rho-related GTP-binding protein RhoG-like
integrin subunit beta 1 binding protein 2, transcript variant X1
integrin subunit beta 1 binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
integrin beta-1-binding protein 2 isoform X2
integrin beta-1-binding protein 2 isoform X1
non-POU domain containing octamer binding, transcript variant X4
non-POU domain containing octamer binding, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
non-POU domain containing octamer binding, transcript variant X2
non-POU domain containing octamer binding, transcript variant X1
non-POU domain containing octamer binding, transcript variant X5
non-POU domain containing octamer binding, transcript variant X6
non-POU domain-containing octamer-binding protein isoform X3
non-POU domain-containing octamer-binding protein isoform X2
non-POU domain-containing octamer-binding protein isoform X1
non-POU domain-containing octamer-binding protein isoform X4
zinc finger MYM-type containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
zinc finger MYM-type containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger MYM-type containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger MYM-type containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger MYM-type containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
zinc finger MYM-type containing 3, transcript variant X2
zinc finger MYM-type containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger MYM-type protein 3 isoform X1
zinc finger MYM-type protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gap junction protein beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction protein beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
gap junction protein beta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
mediator complex subunit 12, transcript variant X3
mediator complex subunit 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
mediator complex subunit 12, transcript variant X1
mediator of RNA polymerase II transcription subunit 12 isoform X3
mediator of RNA polymerase II transcription subunit 12 isoform X2
mediator of RNA polymerase II transcription subunit 12 isoform X1
interleukin 2 receptor subunit gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
interleukin 2 receptor subunit gamma, transcript variant X2
cytokine receptor common subunit gamma isoform X1
cytokine receptor common subunit gamma isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 7 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 7 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
solute carrier family 7 member 3, transcript variant X2
solute carrier family 7 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 7 member 3, transcript variant X5
solute carrier family 7 member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
serine protease 23-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
serine protease 23-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
serine protease 23-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
testis expressed 11, transcript variant X2
testis expressed 11, transcript variant X1
testis expressed 11, transcript variant X3
testis expressed 11, transcript variant X7
testis expressed 11, transcript variant X8
testis expressed 11, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
testis expressed 11, transcript variant X16
testis expressed 11, transcript variant X4
testis expressed 11, transcript variant X18
testis expressed 11, transcript variant X21
testis expressed 11, transcript variant X15
testis expressed 11, transcript variant X20
testis expressed 11, transcript variant X22
testis expressed 11, transcript variant X6
testis expressed 11, transcript variant X12
testis expressed 11, transcript variant X19
testis expressed 11, transcript variant X17
testis expressed 11, transcript variant X5
testis expressed 11, transcript variant X9
testis expressed 11, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
testis expressed 11, transcript variant X23
testis expressed 11, transcript variant X10
testis expressed 11, transcript variant X14
testis expressed 11, transcript variant X13
discs large MAGUK scaffold protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
discs large MAGUK scaffold protein 3, transcript variant X8
discs large MAGUK scaffold protein 3, transcript variant X7
discs large MAGUK scaffold protein 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
glycerophosphodiester phosphodiesterase domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
glycerophosphoinositol inositolphosphodiesterase GDPD2
5-hydroxytryptamine receptor 2C, transcript variant X1
5-hydroxytryptamine receptor 2C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
5-hydroxytryptamine receptor 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 2C isoform X1
5-hydroxytryptamine receptor 2C isoform X2
uncharacterized LOC110403174, transcript variant X4
uncharacterized LOC110403174, transcript variant X1
uncharacterized LOC110403174, transcript variant X3
uncharacterized LOC110403174, transcript variant X2
interleukin 13 receptor subunit alpha 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
interleukin-13 receptor subunit alpha-2 isoform X2
interleukin-13 receptor subunit alpha-2 isoform X1
interleukin-13 receptor subunit alpha-2 isoform X3
UAP56-interacting factor-like, transcript variant X1
UAP56-interacting factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
UAP56-interacting factor-like isoform X2
UAP56-interacting factor-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
angiotensin II receptor type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
angiotensin II receptor type 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
angiotensin II receptor type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
angiotensin II receptor type 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 6 member 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) isoform X1
solute carrier family 6 member 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) isoform X3
solute carrier family 6 member 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) isoform X2
protein FAM162B-like, transcript variant X4
protein FAM162B-like, transcript variant X1
protein FAM162B-like, transcript variant X2
protein FAM162B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC110403257, transcript variant X1
uncharacterized LOC110403257, transcript variant X2
uncharacterized LOC110403257, transcript variant X3
uncharacterized LOC110403256, transcript variant X15
uncharacterized LOC110403256, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC110403256, transcript variant X13
uncharacterized LOC110403256, transcript variant X17
uncharacterized LOC110403256, transcript variant X9
uncharacterized LOC110403256, transcript variant X12
uncharacterized LOC110403256, transcript variant X6
uncharacterized LOC110403256, transcript variant X3
uncharacterized LOC110403256, transcript variant X7
uncharacterized LOC110403256, transcript variant X2
uncharacterized LOC110403256, transcript variant X5
uncharacterized LOC110403256, transcript variant X1
uncharacterized LOC110403256, transcript variant X4
uncharacterized LOC110403256, transcript variant X10
uncharacterized LOC110403256, transcript variant X11
uncharacterized LOC110403256, transcript variant X16
uncharacterized LOC110403256, transcript variant X8
kelch like family member 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
kelch like family member 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
kelch like family member 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
kelch like family member 13, transcript variant X3
kelch like family member 13, transcript variant X5
WD repeat domain 44, transcript variant X1
WD repeat-containing protein 44 isoform X1
WD repeat domain 44, transcript variant X3
WD repeat domain 44, transcript variant X2
WD repeat-containing protein 44 isoform X2
dedicator of cytokinesis 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dedicator of cytokinesis 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dedicator of cytokinesis 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dedicator of cytokinesis 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X1
dedicator of cytokinesis protein 11 isoform X2
dedicator of cytokinesis protein 11 isoform X3
dedicator of cytokinesis protein 11 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
RAP2C, member of RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
RAP2C, member of RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
muscleblind like splicing regulator 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC110403194, transcript variant X1
uncharacterized LOC110403194, transcript variant X2
uncharacterized LOC110403072, transcript variant X10
uncharacterized LOC110403072, transcript variant X2
uncharacterized LOC110403072, transcript variant X3
uncharacterized LOC110403072, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110403072, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC110403072, transcript variant X9
uncharacterized LOC110403072, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC110403072, transcript variant X13
uncharacterized LOC110403072, transcript variant X7
uncharacterized LOC110403072, transcript variant X15
uncharacterized LOC110403072, transcript variant X4
uncharacterized LOC110403072, transcript variant X14
uncharacterized LOC110403072, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC110403072, transcript variant X6
uncharacterized LOC110403072, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PHD finger protein 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
PHD finger protein 6, transcript variant X3
PHD finger protein 6, transcript variant X2
PHD finger protein 6, transcript variant X1
PHD finger protein 6, transcript variant X6
PHD finger protein 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
hypoxanthine phosphoribosyltransferase 1
similar to RNA sequence (same species):INSD:GBYG01001336.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 114 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 27 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
hypoxanthine-guanine phosphoribosyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
motile sperm domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
motile sperm domain containing 1, transcript variant X1
motile sperm domain-containing protein 1 isoform X2
motile sperm domain-containing protein 1 isoform X1
integrator complex subunit 6-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
integrator complex subunit 6-like, transcript variant X5
integrator complex subunit 6-like, transcript variant X8
integrator complex subunit 6-like, transcript variant X7
integrator complex subunit 6-like, transcript variant X1
integrator complex subunit 6-like, transcript variant X2
integrator complex subunit 6-like, transcript variant X3
integrator complex subunit 6-like, transcript variant X4
integrator complex subunit 6-like isoform X1
integrator complex subunit 6-like isoform X2
integrator complex subunit 6-like isoform X3
integrator complex subunit 6-like isoform X4
similar to RNA sequence (same species):INSD:GBYG01002056.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 121 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 82 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01016390.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 117 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 117 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
four and a half LIM domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
four and a half LIM domains 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
four and a half LIM domains protein 1 isoform X3
four and a half LIM domains 1, transcript variant X6
four and a half LIM domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
four and a half LIM domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
four and a half LIM domains 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
four and a half LIM domains protein 1 isoform X1
four and a half LIM domains protein 1 isoform X2
MAP7 domain containing 3, transcript variant X5
MAP7 domain containing 3, transcript variant X3
MAP7 domain containing 3, transcript variant X4
MAP7 domain containing 3, transcript variant X2
MAP7 domain containing 3, transcript variant X1
MAP7 domain containing 3, transcript variant X9
MAP7 domain containing 3, transcript variant X8
MAP7 domain containing 3, transcript variant X7
MAP7 domain containing 3, transcript variant X6
MAP7 domain-containing protein 3 isoform X2
MAP7 domain-containing protein 3 isoform X9
MAP7 domain-containing protein 3 isoform X8
MAP7 domain-containing protein 3 isoform X5
MAP7 domain-containing protein 3 isoform X3
MAP7 domain-containing protein 3 isoform X7
MAP7 domain-containing protein 3 isoform X6
MAP7 domain-containing protein 3 isoform X4
MAP7 domain-containing protein 3 isoform X1
adhesion G-protein coupled receptor G4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor G4, transcript variant X2
adhesion G protein-coupled receptor G4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
vestigial like family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vestigial like family member 1, transcript variant X2
transcription cofactor vestigial-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X2
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rho guanine nucleotide exchange factor 6 isoform X3
rho guanine nucleotide exchange factor 6 isoform X2
rho guanine nucleotide exchange factor 6 isoform X1
RNA binding motif protein, X-linked, transcript variant X3
RNA binding motif protein, X-linked, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RNA binding motif protein, X-linked, transcript variant X2
RNA-binding motif protein, X chromosome isoform X2
RNA-binding motif protein, X chromosome isoform X1
transmembrane 9 superfamily member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110403472, transcript variant X1
uncharacterized LOC110403472, transcript variant X2
uncharacterized LOC110403428, transcript variant X1
uncharacterized LOC110403428, transcript variant X2
uncharacterized LOC110403404, transcript variant X2
uncharacterized LOC110403404, transcript variant X1
fibroblast growth factor 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fibroblast growth factor 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
fibroblast growth factor 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
fibroblast growth factor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coagulation factor IX, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
coagulation factor IX, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
coagulation factor IX, transcript variant X3
MCF.2 cell line derived transforming sequence, transcript variant X1
MCF.2 cell line derived transforming sequence, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X6
ATPase phospholipid transporting 11C, transcript variant X5
ATPase phospholipid transporting 11C, transcript variant X4
ATPase phospholipid transporting 11C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phospholipid-transporting ATPase IG isoform X6
ATPase phospholipid transporting 11C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phospholipid-transporting ATPase IG isoform X3
phospholipid-transporting ATPase IG isoform X5
phospholipid-transporting ATPase IG isoform X4
phospholipid-transporting ATPase IG isoform X1
phospholipid-transporting ATPase IG isoform X2
ADP-ribosylation factor-like protein 13A
uncharacterized LOC110403259, transcript variant X2
uncharacterized protein LOC110403259 isoform X2
uncharacterized LOC110403259, transcript variant X1
uncharacterized LOC110403259, transcript variant X3
uncharacterized protein LOC110403259 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cleavage stimulation factor subunit 2, transcript variant X3
cleavage stimulation factor subunit 2, transcript variant X2
cleavage stimulation factor subunit 2, transcript variant X1
cleavage stimulation factor subunit 2 isoform X3
cleavage stimulation factor subunit 2 isoform X2
cleavage stimulation factor subunit 2 isoform X1
tRNA methyltransferase 12 homolog, transcript variant X1
tRNA wybutosine-synthesizing protein 2 homolog isoform X1
tRNA methyltransferase 12 homolog, transcript variant X2
tRNA wybutosine-synthesizing protein 2 homolog isoform X2
synaptotagmin like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
synaptotagmin like 4, transcript variant X2
sushi repeat containing protein, X-linked 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC110403280, transcript variant X2
uncharacterized LOC110403280, transcript variant X1
uncharacterized LOC110403280, transcript variant X3
diaphanous related formin 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
diaphanous related formin 2, transcript variant X3
diaphanous related formin 2, transcript variant X2
diaphanous related formin 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110403001, transcript variant X4
uncharacterized LOC110403001, transcript variant X5
uncharacterized LOC110403001, transcript variant X12
uncharacterized LOC110403001, transcript variant X11
uncharacterized LOC110403001, transcript variant X10
uncharacterized LOC110403001, transcript variant X9
uncharacterized LOC110403001, transcript variant X7
uncharacterized LOC110403001, transcript variant X6
uncharacterized LOC110403001, transcript variant X1
uncharacterized LOC110403001, transcript variant X2
uncharacterized LOC110403001, transcript variant X3
uncharacterized LOC110403001, transcript variant X8
uncharacterized LOC110403002, transcript variant X1
uncharacterized LOC110403002, transcript variant X2
uncharacterized LOC110403212, transcript variant X1
uncharacterized LOC110403212, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC110403473, transcript variant X2
uncharacterized LOC110403473, transcript variant X1
uncharacterized LOC110403051, transcript variant X2
uncharacterized LOC110403051, transcript variant X1
uncharacterized LOC110403048, transcript variant X1
uncharacterized LOC110403048, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X1
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X6
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X7
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X3
rab proteins geranylgeranyltransferase component A 1-like isoform X4
rab proteins geranylgeranyltransferase component A 1-like isoform X1
rab proteins geranylgeranyltransferase component A 1-like isoform X2
rab proteins geranylgeranyltransferase component A 1-like isoform X5
rab proteins geranylgeranyltransferase component A 1-like isoform X6
rab proteins geranylgeranyltransferase component A 1-like isoform X3
uncharacterized LOC110403049, transcript variant X3
uncharacterized LOC110403049, transcript variant X4
uncharacterized LOC110403049, transcript variant X2
uncharacterized LOC110403049, transcript variant X1
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1-like, transcript variant X9
zinc finger protein 711, transcript variant X4
zinc finger protein 711, transcript variant X1
zinc finger protein 711, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger protein 711, transcript variant X2
zinc finger protein 711, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC110403144, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110403144, transcript variant X1
uncharacterized protein LOC110403144 isoform X1
uncharacterized protein LOC110403144 isoform X2
connector enhancer of kinase suppressor of ras 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: connector enhancer of kinase suppressor of ras 2-like
highly divergent homeobox, transcript variant X4
highly divergent homeobox, transcript variant X3
highly divergent homeobox, transcript variant X1
highly divergent homeobox, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ribosomal protein S6 kinase A6, transcript variant X1
ribosomal protein S6 kinase A6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ribosomal protein S6 kinase alpha-6 isoform X1
ribosomal protein S6 kinase alpha-6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 3, transcription factor 4
sodium/hydrogen exchanger 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/hydrogen exchanger 2-like isoform X2
sodium/hydrogen exchanger 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/hydrogen exchanger 2-like, transcript variant X3
sodium/hydrogen exchanger 2-like isoform X1
sodium/hydrogen exchanger 2-like isoform X3
uncharacterized protein CXorf21-like, transcript variant X2
uncharacterized protein CXorf21-like, transcript variant X3
uncharacterized protein CXorf21-like, transcript variant X1
SH3 domain binding glutamate rich protein like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SH3 domain binding glutamate rich protein like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
SH3 domain-binding glutamic acid-rich-like protein isoform X2
SH3 domain-binding glutamic acid-rich-like protein isoform X1
non-histone chromosomal protein HMG-14A, transcript variant X4
non-histone chromosomal protein HMG-14A, transcript variant X2
non-histone chromosomal protein HMG-14A, transcript variant X1
non-histone chromosomal protein HMG-14A, transcript variant X3
bromodomain and WD repeat domain containing 3, transcript variant X3
bromodomain and WD repeat domain containing 3, transcript variant X1
bromodomain and WD repeat domain containing 3, transcript variant X2
bromodomain and WD repeat-containing protein 3 isoform X1
bromodomain and WD repeat-containing protein 3 isoform X3
bromodomain and WD repeat-containing protein 3 isoform X2
uncharacterized LOC110403225, transcript variant X1
uncharacterized LOC110403225, transcript variant X2
protein FAM46C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein FAM46C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
protein FAM46C-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein FAM46C-like, transcript variant X2
protein FAM46C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein FAM46C-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
H(+)/Cl(-) exchange transporter 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 5 isoform X2
H(+)/Cl(-) exchange transporter 5 isoform X1
H(+)/Cl(-) exchange transporter 5, transcript variant X5
H(+)/Cl(-) exchange transporter 5 isoform X3
tumor necrosis factor ligand superfamily member 10-like
uncharacterized LOC110403411, transcript variant X1
uncharacterized LOC110403411, transcript variant X2
SLIT and NTRK like family member 4, transcript variant X2
SLIT and NTRK like family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-4 isoform X2
gamma-aminobutyric acid receptor subunit beta-4 isoform X1
gamma-aminobutyric acid receptor subunit beta-4 isoform X3
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X4
gamma-aminobutyric acid type A receptor alpha3 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor alpha3 subunit, transcript variant X1
gamma-aminobutyric acid receptor subunit alpha-3 isoform X1
gamma-aminobutyric acid type A receptor alpha3 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-3 isoform X2
gamma-aminobutyric acid type A receptor alpha3 subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit gamma-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclic nucleotide gated channel alpha 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclic nucleotide gated channel alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclic nucleotide gated channel alpha 2, transcript variant X1
cyclic nucleotide-gated olfactory channel isoform X1
cyclic nucleotide-gated olfactory channel isoform X2
uncharacterized LOC110403186, transcript variant X6
uncharacterized LOC110403186, transcript variant X7
uncharacterized LOC110403186, transcript variant X4
uncharacterized LOC110403186, transcript variant X3
uncharacterized LOC110403186, transcript variant X1
uncharacterized LOC110403186, transcript variant X5
uncharacterized LOC110403186, transcript variant X2
uncharacterized protein LOC110403186 isoform X4
uncharacterized protein LOC110403186 isoform X2
uncharacterized protein LOC110403186 isoform X3
uncharacterized protein LOC110403186 isoform X1
proline rich and Gla domain 3, transcript variant X2
proline rich and Gla domain 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
proline rich and Gla domain 3, transcript variant X7
proline rich and Gla domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proline rich and Gla domain 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
proline rich and Gla domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline rich and Gla domain 3, transcript variant X3
proline rich and Gla domain 3, transcript variant X1
proline rich and Gla domain 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane gamma-carboxyglutamic acid protein 3 isoform X2
transmembrane gamma-carboxyglutamic acid protein 3 isoform X1
transmembrane gamma-carboxyglutamic acid protein 3 isoform X3
proline rich and Gla domain 3, transcript variant X11
proline rich and Gla domain 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte cell adhesion molecule-like, transcript variant X3
hepatocyte cell adhesion molecule-like, transcript variant X7
hepatocyte cell adhesion molecule-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
hepatocyte cell adhesion molecule-like, transcript variant X8
hepatocyte cell adhesion molecule-like, transcript variant X1
hepatocyte cell adhesion molecule-like, transcript variant X5
hepatocyte cell adhesion molecule-like, transcript variant X2
hepatocyte cell adhesion molecule-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
hepatocyte cell adhesion molecule-like isoform X2
hepatocyte cell adhesion molecule-like isoform X1
hepatocyte cell adhesion molecule-like isoform X3
uncharacterized LOC110403156, transcript variant X7
uncharacterized LOC110403156, transcript variant X12
uncharacterized LOC110403156, transcript variant X9
uncharacterized LOC110403156, transcript variant X15
uncharacterized LOC110403156, transcript variant X5
uncharacterized LOC110403156, transcript variant X4
uncharacterized LOC110403156, transcript variant X2
uncharacterized LOC110403156, transcript variant X10
uncharacterized LOC110403156, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC110403156, transcript variant X6
uncharacterized LOC110403156, transcript variant X3
uncharacterized protein LOC110403156 isoform X7
uncharacterized protein LOC110403156 isoform X2
uncharacterized protein LOC110403156 isoform X5
uncharacterized protein LOC110403156 isoform X4
uncharacterized protein LOC110403156 isoform X1
uncharacterized protein LOC110403156 isoform X10
uncharacterized protein LOC110403156 isoform X3
uncharacterized protein LOC110403156 isoform X13
uncharacterized protein LOC110403156 isoform X8
uncharacterized LOC110403156, transcript variant X11
uncharacterized LOC110403156, transcript variant X14
uncharacterized LOC110403156, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized protein LOC110403156 isoform X12
uncharacterized protein LOC110403156 isoform X9
uncharacterized LOC110403156, transcript variant X13
uncharacterized protein LOC110403156 isoform X11
uncharacterized protein LOC110403156 isoform X6
uncharacterized LOC110403217, transcript variant X3
uncharacterized LOC110403217, transcript variant X2
uncharacterized LOC110403217, transcript variant X1
uncharacterized LOC110403217, transcript variant X4
uncharacterized protein LOC110403217 isoform X3
uncharacterized protein LOC110403217 isoform X2
uncharacterized protein LOC110403217 isoform X1
uncharacterized protein LOC110403217 isoform X4
trimethyllysine hydroxylase, epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
trimethyllysine hydroxylase, epsilon, transcript variant X1
trimethyllysine dioxygenase, mitochondrial
sprouty RTK signaling antagonist 3, transcript variant X3
sprouty RTK signaling antagonist 3, transcript variant X1
sprouty RTK signaling antagonist 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
brain-specific homeobox/POU domain protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC110403469, transcript variant X2
uncharacterized LOC110403469, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA-directed RNA polymerases I and III subunit RPAC2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
DNA-directed RNA polymerases I and III subunit RPAC2-like isoform X1
DNA-directed RNA polymerases I and III subunit RPAC2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DNA-directed RNA polymerases I and III subunit RPAC2-like, transcript variant X2
DNA-directed RNA polymerases I and III subunit RPAC2-like isoform X3
DNA-directed RNA polymerases I and III subunit RPAC2-like isoform X2
vesicle associated membrane protein 7, transcript variant X3
vesicle associated membrane protein 7, transcript variant X1
vesicle associated membrane protein 7, transcript variant X2
SLAIN motif-containing protein-like, transcript variant X3
SLAIN motif-containing protein-like, transcript variant X2
SLAIN motif-containing protein-like, transcript variant X1
SLAIN motif-containing protein-like isoform X2
SLAIN motif-containing protein-like isoform X3
SLAIN motif-containing protein-like isoform X1
zinc finger protein 185 with LIM domain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger protein 185 with LIM domain, transcript variant X3
zinc finger protein 185 with LIM domain, transcript variant X4
zinc finger protein 185 with LIM domain, transcript variant X5
zinc finger protein 185 with LIM domain, transcript variant X9
zinc finger protein 185 with LIM domain, transcript variant X10
zinc finger protein 185 with LIM domain, transcript variant X8
zinc finger protein 185 with LIM domain, transcript variant X6
zinc finger protein 185 with LIM domain, transcript variant X7
zinc finger protein 185 with LIM domain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
NAD(P) dependent steroid dehydrogenase-like, transcript variant X1
NAD(P) dependent steroid dehydrogenase-like, transcript variant X2
NAD(P) dependent steroid dehydrogenase-like, transcript variant X3
sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
glyoxalase domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glyoxalase domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
exocyst complex component 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
exocyst complex component 1-like, transcript variant X3
exocyst complex component 1-like, transcript variant X4
exocyst complex component 1-like, transcript variant X6
exocyst complex component 1-like, transcript variant X2
exocyst complex component 1-like, transcript variant X1
exocyst complex component 1-like isoform X2
exocyst complex component 1-like isoform X1
exocyst complex component 1-like isoform X3
BTB/POZ domain-containing protein KCTD12-like
BTB/POZ domain-containing protein KCTD16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Krueppel-like factor 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Krueppel-like factor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Krueppel-like factor 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Krueppel-like factor 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Krueppel-like factor 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Kruppel like factor 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Kruppel like factor 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Kruppel like factor 8, transcript variant X1
Kruppel like factor 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Kruppel like factor 8, transcript variant X8
Kruppel like factor 8, transcript variant X3
Kruppel like factor 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kruppel like factor 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
chromosome 8 C8orf48 homolog, transcript variant X17
chromosome 8 C8orf48 homolog, transcript variant X15
chromosome 8 C8orf48 homolog, transcript variant X19
chromosome 8 C8orf48 homolog, transcript variant X18
chromosome 8 C8orf48 homolog, transcript variant X8
chromosome 8 C8orf48 homolog, transcript variant X9
chromosome 8 C8orf48 homolog, transcript variant X10
chromosome 8 C8orf48 homolog, transcript variant X7
chromosome 8 C8orf48 homolog, transcript variant X3
chromosome 8 C8orf48 homolog, transcript variant X6
chromosome 8 C8orf48 homolog, transcript variant X11
chromosome 8 C8orf48 homolog, transcript variant X5
chromosome 8 C8orf48 homolog, transcript variant X2
chromosome 8 C8orf48 homolog, transcript variant X1
chromosome 8 C8orf48 homolog, transcript variant X12
chromosome 8 C8orf48 homolog, transcript variant X4
chromosome 8 C8orf48 homolog, transcript variant X16
chromosome 8 C8orf48 homolog, transcript variant X14
chromosome 8 C8orf48 homolog, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C8orf48 homolog isoform X2
uncharacterized protein C8orf48 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 12, transcript variant X5
ankyrin repeat and SOCS box containing 12, transcript variant X3
ankyrin repeat and SOCS box containing 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat and SOCS box protein 12 isoform X2
ankyrin repeat and SOCS box protein 12 isoform X1
ankyrin repeat and SOCS box protein 12 isoform X3
APC membrane recruitment protein 1, transcript variant X1
APC membrane recruitment protein 1, transcript variant X2
Cdc42 guanine nucleotide exchange factor 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Cdc42 guanine nucleotide exchange factor 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Cdc42 guanine nucleotide exchange factor 9, transcript variant X5
Cdc42 guanine nucleotide exchange factor 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Cdc42 guanine nucleotide exchange factor 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho guanine nucleotide exchange factor 9 isoform X2
rho guanine nucleotide exchange factor 9 isoform X1
rho guanine nucleotide exchange factor 9 isoform X3
Cdc42 guanine nucleotide exchange factor 9, transcript variant X7
Cdc42 guanine nucleotide exchange factor 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
rho guanine nucleotide exchange factor 9 isoform X4
vascular endothelial growth factor receptor kdr-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
vascular endothelial growth factor receptor kdr-like, transcript variant X3
vascular endothelial growth factor receptor kdr-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
vascular endothelial growth factor receptor kdr-like isoform X1
vascular endothelial growth factor receptor kdr-like isoform X3
vascular endothelial growth factor receptor kdr-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
homeobox protein CDX-4-like, transcript variant X1
homeobox protein CDX-4-like, transcript variant X2
cysteine-rich hydrophobic domain-containing protein 1
pre-mRNA 3'-end-processing factor FIP1-like
ligand of Numb protein X 2-like, transcript variant X4
ligand of Numb protein X 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ligand of Numb protein X 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ligand of Numb protein X 2-like, transcript variant X7
ligand of Numb protein X 2-like, transcript variant X2
ligand of Numb protein X 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ligand of Numb protein X 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ligand of Numb protein X 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ligand of Numb protein X 2-like isoform X4
ligand of Numb protein X 2-like isoform X3
ligand of Numb protein X 2-like isoform X2
ligand of Numb protein X 2-like isoform X1
ligand of Numb protein X 2-like isoform X6
ligand of Numb protein X 2-like isoform X5
ligand of Numb protein X 2-like isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 12-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 12-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 12-like isoform X1
ubiquitin carboxyl-terminal hydrolase 12-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 12-like isoform X2
ubiquitin carboxyl-terminal hydrolase 12-like isoform X3
wiskott-Aldrich syndrome protein family member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein, LIM domain interacting, transcript variant X3
ring finger protein, LIM domain interacting, transcript variant X1
ring finger protein, LIM domain interacting, transcript variant X2
E3 ubiquitin-protein ligase RLIM isoform X2
E3 ubiquitin-protein ligase RLIM isoform X1
neurite extension and migration factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neurite extension and migration factor, transcript variant X1
ATP binding cassette subfamily B member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ATP binding cassette subfamily B member 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ATP binding cassette subfamily B member 7, transcript variant X1
ATP binding cassette subfamily B member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP binding cassette subfamily B member 7, transcript variant X5
ATP-binding cassette sub-family B member 7, mitochondrial isoform X1
ATP-binding cassette sub-family B member 7, mitochondrial isoform X2
ATP-binding cassette sub-family B member 7, mitochondrial isoform X3
ATP-binding cassette sub-family B member 7, mitochondrial isoform X4
uracil phosphoribosyltransferase homolog
zinc finger DHHC-type containing 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger DHHC-type containing 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger DHHC-type containing 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC110403458, transcript variant X2
uncharacterized LOC110403458, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ATRX, chromatin remodeler, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ATRX, chromatin remodeler, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ATRX, chromatin remodeler, transcript variant X4
ATRX, chromatin remodeler, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ATRX, chromatin remodeler, transcript variant X3
ATRX, chromatin remodeler, transcript variant X5
transcriptional regulator ATRX isoform X6
transcriptional regulator ATRX isoform X4
transcriptional regulator ATRX isoform X2
transcriptional regulator ATRX isoform X1
transcriptional regulator ATRX isoform X3
transcriptional regulator ATRX isoform X5
magnesium transporter 1, transcript variant X1
magnesium transporter 1, transcript variant X2
magnesium transporter protein 1 isoform X1
magnesium transporter 1, transcript variant X3
magnesium transporter 1, transcript variant X4
magnesium transporter protein 1 isoform X2
magnesium transporter protein 1 isoform X3
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase subunit 7B, mitochondrial
ATPase copper transporting alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ATPase copper transporting alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC110402989, transcript variant X2
uncharacterized LOC110402989, transcript variant X3
uncharacterized LOC110402989, transcript variant X1
uncharacterized LOC110402987, transcript variant X1
uncharacterized LOC110402987, transcript variant X2
transient receptor potential cation channel subfamily C member 5, transcript variant X1
transient receptor potential cation channel subfamily C member 5, transcript variant X2
short transient receptor potential channel 5
ALG13, UDP-N-acetylglucosaminyltransferase subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13
neuronal migration protein doublecortin isoform X2
neuronal migration protein doublecortin isoform X3
neuronal migration protein doublecortin isoform X4
neuronal migration protein doublecortin isoform X5
neuronal migration protein doublecortin isoform X1
neuronal migration protein doublecortin isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
p21 (RAC1) activated kinase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
p21 (RAC1) activated kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
p21 (RAC1) activated kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC110403314, transcript variant X1
uncharacterized LOC110403314, transcript variant X2
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC110403313, transcript variant X1
uncharacterized LOC110403313, transcript variant X2
transmembrane protein 164, transcript variant X1
transmembrane protein 164, transcript variant X2
transmembrane protein 164, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
acyl-CoA synthetase long-chain family member 4, transcript variant X1
acyl-CoA synthetase long-chain family member 4, transcript variant X3
acyl-CoA synthetase long-chain family member 4, transcript variant X4
acyl-CoA synthetase long-chain family member 4, transcript variant X5
acyl-CoA synthetase long-chain family member 4, transcript variant X6
acyl-CoA synthetase long-chain family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 4 isoform X1
long-chain-fatty-acid--CoA ligase 4 isoform X2
potassium voltage-gated channel subfamily E regulatory subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily E regulatory beta subunit 5
nuclear transport factor 2 like export factor 2, transcript variant X2
nuclear transport factor 2 like export factor 2, transcript variant X1
nuclear transport factor 2 like export factor 2, transcript variant X3
basic salivary proline-rich protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
collagen type IV alpha 5 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
collagen type IV alpha 5 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
collagen type IV alpha 5 chain, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
collagen type IV alpha 5 chain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
collagen type IV alpha 5 chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
collagen type IV alpha 6 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
collagen type IV alpha 6 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
collagen type IV alpha 6 chain, transcript variant X3
autophagy related 4A cysteine peptidase, transcript variant X1
autophagy related 4A cysteine peptidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
proteasome 26S subunit, non-ATPase 10, transcript variant X4
proteasome 26S subunit, non-ATPase 10, transcript variant X3
proteasome 26S subunit, non-ATPase 10, transcript variant X2
proteasome 26S subunit, non-ATPase 10, transcript variant X1
26S proteasome non-ATPase regulatory subunit 10 isoform X2
26S proteasome non-ATPase regulatory subunit 10 isoform X1
V-set and immunoglobulin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
V-set and immunoglobulin domain containing 1, transcript variant X2
V-set and immunoglobulin domain-containing protein 1 isoform X2
V-set and immunoglobulin domain-containing protein 1 isoform X1
V-set and immunoglobulin domain containing 1, transcript variant X3
V-set and immunoglobulin domain-containing protein 1 isoform X3
synaptotagmin-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
synaptotagmin-like protein 1, transcript variant X2
synaptotagmin-like protein 1, transcript variant X3
similar to RNA sequence (same species):INSD:GBYG01026469.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 348 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 254 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
VHL binding protein 1, transcript variant X1
VHL binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein-like isoform X5
phosphatidylinositol-binding clathrin assembly protein-like isoform X2
phosphatidylinositol-binding clathrin assembly protein-like isoform X4
phosphatidylinositol-binding clathrin assembly protein-like isoform X6
phosphatidylinositol-binding clathrin assembly protein-like isoform X3
phosphatidylinositol-binding clathrin assembly protein-like isoform X1
GRB2 associated binding protein 3, transcript variant X2
GRB2 associated binding protein 3, transcript variant X1
GRB2-associated-binding protein 3 isoform X2
GRB2-associated-binding protein 3 isoform X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
probable global transcription activator SNF2L1
uncharacterized LOC110403409, transcript variant X2
uncharacterized LOC110403409, transcript variant X1
teneurin transmembrane protein 1, transcript variant X1
teneurin transmembrane protein 1, transcript variant X2
teneurin transmembrane protein 1, transcript variant X3
teneurin transmembrane protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110403276, transcript variant X2
uncharacterized LOC110403276, transcript variant X1
stromal antigen 2, transcript variant X3
stromal antigen 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
stromal antigen 2, transcript variant X5
stromal antigen 2, transcript variant X1
stromal antigen 2, transcript variant X4
X-linked inhibitor of apoptosis, transcript variant X1
X-linked inhibitor of apoptosis, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
X-linked inhibitor of apoptosis, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X11
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X9
sosondowah ankyrin repeat domain family member D
ankyrin repeat domain-containing protein SOWAHD
C1GALT1 specific chaperone 1, transcript variant X1
C1GALT1 specific chaperone 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
C1GALT1 specific chaperone 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
lysosomal associated membrane protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
lysosomal associated membrane protein 2, transcript variant X1
lysosomal associated membrane protein 2, transcript variant X3
lysosome-associated membrane glycoprotein 2 isoform X2
lysosome-associated membrane glycoprotein 2 isoform X1
lysosome-associated membrane glycoprotein 2 isoform X3
ATPase Na+/K+ transporting family member beta 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 255A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transmembrane protein 255A, transcript variant X4
transmembrane protein 255A, transcript variant X3
transmembrane protein 255A, transcript variant X1
transmembrane protein 255A, transcript variant X2
zinc finger and BTB domain containing 33
A-kinase anchoring protein 14, transcript variant X1
A-kinase anchoring protein 14, transcript variant X2
NADH:ubiquinone oxidoreductase subunit A1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1
UPF3B, regulator of nonsense mediated mRNA decay
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
testis-specific serine/threonine-protein kinase 6-like
progesterone receptor membrane component 1
membrane-associated progesterone receptor component 1
KIAA1210 ortholog, transcript variant X5
KIAA1210 ortholog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
KIAA1210 ortholog, transcript variant X2
KIAA1210 ortholog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KIAA1210 ortholog, transcript variant X3
KIAA1210 ortholog, transcript variant X1
uncharacterized protein KIAA1210 homolog isoform X1
uncharacterized protein KIAA1210 homolog isoform X3
uncharacterized protein KIAA1210 homolog isoform X2
uncharacterized protein KIAA1210 homolog isoform X4
KIAA1210 ortholog, transcript variant X6
KIAA1210 ortholog, transcript variant X8
uncharacterized protein KIAA1210 homolog isoform X5
KIAA1210 ortholog, transcript variant X9
uncharacterized protein KIAA1210 homolog isoform X6
LON peptidase N-terminal domain and ring finger 3
similar to RNA sequence (same species):INSD:GBYG01017280.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 538 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 538 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
LON peptidase N-terminal domain and RING finger protein 3
family with sequence similarity 199, X-linked, transcript variant X2
family with sequence similarity 199, X-linked, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
interleukin 1 receptor accessory protein like 2, transcript variant X2
interleukin 1 receptor accessory protein like 2, transcript variant X4
interleukin 1 receptor accessory protein like 2, transcript variant X6
interleukin 1 receptor accessory protein like 2, transcript variant X3
interleukin 1 receptor accessory protein like 2, transcript variant X1
interleukin 1 receptor accessory protein like 2, transcript variant X7
interleukin 1 receptor accessory protein like 2, transcript variant X9
interleukin 1 receptor accessory protein like 2, transcript variant X10
interleukin 1 receptor accessory protein like 2, transcript variant X5
interleukin 1 receptor accessory protein like 2, transcript variant X8
interleukin 1 receptor accessory protein like 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
interleukin 1 receptor accessory protein like 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interleukin 1 receptor accessory protein like 2, transcript variant X12
X-linked interleukin-1 receptor accessory protein-like 2 isoform X1
X-linked interleukin-1 receptor accessory protein-like 2 isoform X2
interleukin 1 receptor accessory protein like 2, transcript variant X14
X-linked interleukin-1 receptor accessory protein-like 2 isoform X3
Nik related kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Nik related kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Nik related kinase, transcript variant X3
Nik related kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Nik related kinase, transcript variant X4
Nik related kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ring finger protein 128, E3 ubiquitin protein ligase
TBC1 domain family member 8B, transcript variant X2
TBC1 domain family member 8B, transcript variant X3
TBC1 domain family member 8B, transcript variant X4
TBC1 domain family member 8B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
PAS domain containing repressor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
PAS domain containing repressor 1, transcript variant X4
PAS domain containing repressor 1, transcript variant X10
PAS domain containing repressor 1, transcript variant X3
PAS domain containing repressor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
PAS domain containing repressor 1, transcript variant X6
PAS domain containing repressor 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
PAS domain containing repressor 1, transcript variant X5
PAS domain containing repressor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
PAS domain containing repressor 1, transcript variant X7
circadian clock protein PASD1 isoform X6
circadian clock protein PASD1 isoform X5
circadian clock protein PASD1 isoform X4
circadian clock protein PASD1 isoform X3
circadian clock protein PASD1 isoform X2
circadian clock protein PASD1 isoform X1
circadian clock protein PASD1 isoform X7
vacuolar ATPase assembly integral membrane protein VMA21
G protein-coupled receptor 50, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
G protein-coupled receptor 50, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
G protein-coupled receptor 50, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
G protein-coupled receptor 50, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
G protein-coupled receptor 50, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
G protein-coupled receptor 50, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01017658.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 71 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 55 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
myotubularin related protein 1, transcript variant X2
myotubularin related protein 1, transcript variant X3
myotubularin related protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
myotubularin-related protein 1 isoform X2
myotubularin-related protein 1 isoform X3
myotubularin-related protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
mastermind like domain containing 1, transcript variant X2
mastermind like domain containing 1, transcript variant X1
mastermind-like domain-containing protein 1 isoform X2
mastermind-like domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X1
iduronate 2-sulfatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
fragile X mental retardation 1 neighbor protein
fragile X mental retardation 1, transcript variant X2
similar to RNA sequence (same species):INSD:GBYG01018196.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 183 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
fragile X mental retardation 1, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 183 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 51 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
synaptic functional regulator FMR1 isoform X2
synaptic functional regulator FMR1 isoform X1
fragile X mental retardation 1, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 183 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
synaptic functional regulator FMR1 isoform X4
fragile X mental retardation 1, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 183 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
synaptic functional regulator FMR1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments